Brinda Balakrishnan serves as Executive at Aurinia Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Brinda Balakrishnan has executed 3 insider transactions totaling $3.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 21, 2024 involved selling 520 shares valued at $3.0K.
Brinda Balakrishnan currently holds 17,523 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brinda Balakrishnan has been a net seller of AUPH stock. They have purchased $0 and sold $3.0K worth of shares.
Brinda Balakrishnan's most recent insider trade was on May 21, 2024, when they sold 520 shares at $5.74 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 18, 2023 | AUPH | $0 | Option Exercise | 8,733 | $N/A | Discretionary |